Quantum Leap provides update on I-SPY 2 breast cancer trial

Quantum Leap Healthcare Collaborative provided an update on the overall progress of the Phase II I-SPY 2 trial evaluating neoadjuvant treatments for breast cancer in patients at high risk for

Read the full 300 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE